Cargando…
EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders
Different mutations occurring in the unstable CGG repeat in 5' untranslated region of FMR1 gene are responsible for three fragile X-associated disorders. An expansion of over ∼200 CGG repeats when associated with abnormal methylation and inactivation of the promoter is the mutation termed ‘full...
Autores principales: | Biancalana, Valérie, Glaeser, Dieter, McQuaid, Shirley, Steinbach, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666582/ https://www.ncbi.nlm.nih.gov/pubmed/25227148 http://dx.doi.org/10.1038/ejhg.2014.185 |
Ejemplares similares
-
EMQN best practice guidelines for genetic testing in dystrophinopathies
por: Fratter, Carl, et al.
Publicado: (2020) -
EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease
por: Losekoot, Monique, et al.
Publicado: (2013) -
EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
por: Baumgartner-Parzer, Sabina, et al.
Publicado: (2020) -
EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH)
por: Porto, Graça, et al.
Publicado: (2016) -
EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies
por: Traeger-Synodinos, Joanne, et al.
Publicado: (2015)